Data / Drug companies / Maeda Inc
Maeda Inc: 18 products in the FDA NDC directory, labeler code 86184
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Maeda Inc (labeler code 86184) lists 18 products in the FDA National Drug Code Directory. By type: 18 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 27, 2026.
The request: Watch Maeda Inc (FDA labeler code 86184): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 86184
- Products in commercial distribution
- 18
- Packages
- 18
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 12
- Earliest marketing start
- August 20, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 18 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 18 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 18 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Leflunomide | 86184-223 | Powder | Bulk ingredients | October 27, 2026 |
| Ketotifen fumarate | 86184-201 | Powder | Bulk ingredients | October 21, 2026 |
| Glycyrrhizinate dipotassium | 86184-124 | Powder | Bulk ingredients | October 21, 2026 |
| Cromolyn sodium | 86184-053 | Powder | Bulk ingredients | October 21, 2026 |
| Mitotane | 86184-250 | Powder | Bulk ingredients | September 29, 2026 |
| Sodium acetate trihydrate | 86184-369 | Powder | Bulk ingredients | June 17, 2026 |
| Acetylcysteine | 86184-011 | Powder | Bulk ingredients | May 18, 2026 |
| Palbociclib | 86184-314 | Powder | Bulk ingredients | May 11, 2026 |
| Nalbuphine hydrochloride | 86184-262 | Powder | Bulk ingredients | March 27, 2026 |
| Paroxetine hydrochloride hemihydrate | 86184-302 | Powder | Bulk ingredients | March 4, 2026 |
| Dasatinib monohydrate | 86184-062 | Powder | Bulk ingredients | February 27, 2026 |
| Melphalan | 86184-243 | Powder | Bulk ingredients | November 20, 2025 |
| Gramicidin | 86184-123 | Powder | Bulk ingredients | October 21, 2025 |
| Glipizide | 86184-122 | Powder | Bulk ingredients | October 20, 2025 |
| Cisplatin | 86184-048 | Powder | Bulk ingredients | October 15, 2025 |
| N-acetyl-d-glucosamine | 86184-261 | Powder | Bulk ingredients | September 26, 2025 |
| Megestrol acetate | 86184-256 | Powder | Bulk ingredients | September 10, 2025 |
| Paromomycin sulfate | 86184-301 | Powder | Bulk ingredients | August 20, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.